A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure

Show other versions (1)

Background Beta-blockers (BBs) are the mainstay prognostic medication for all stages of chronic heart failure (CHF). There are many classes of BBs, each of which has varying levels of evidence to support its efficacy in CHF. However, most CHF patients have one or more comorbid conditions such as dia...

Full description

Bibliographic Details
Main Authors:	Pupalan Iyngkaran, Samia R. Toukhsati, Merlin C. Thomas, Michael V. Jelinek, David L. Hare, John D. Horowitz
Format:	Article
Language:	English
Published:	SAGE Publishing 2016-01-01
Series:	Clinical Medicine Insights: Cardiology
Online Access:	https://doi.org/10.4137/CMC.S38444

Similar Items

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure
by: Pupalan Iyngkaran, et al.
Published: (2016-10-01)

Beta-blockers in chronic heart failure
by: Al-Nasser, Faisal
Published: (2004)

Moving From Heart Failure Guidelines to Clinical Practice: Gaps Contributing to Readmissions in Patients With Multiple Comorbidities and Older Age
by: Pupalan Iyngkaran, et al.
Published: (2018-12-01)

HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA
by: A. A. Aleksandrov, et al.
Published: (2016-01-01)

Beta-Blockers in Atrial Fibrillation Patients with Heart Failure
by: Yi-Jung Wu, et al.
Published: (2017)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
by: Kazufumi Nakamura, et al.
Published: (2011-08-01)

NEW ADVANCES IN BETA-BLOCKER THERAPY IN HEART FAILURE
by: Vincenzo eBarrese, et al.
Published: (2013-11-01)

Beta-blockers in chronic heart failure in elderly patient
by: Alberto De Bernardi
Published: (2009-06-01)

The effect of beta-blockers in acute heart failure according to heart rate
by: Hyun-Jin Kim, et al.
Published: (2021-07-01)

OPTIMAL USE OF BETA-BLOCKERS IN CASE OF CHRONIC HEART FAILURE
by: N. A. Shostak, et al.
Published: (2016-09-01)

Are beta-blockers effective in heart failure with preserved ejection fraction?
by: Javier Alegría, et al.
Published: (2016-12-01)

Effect of beta blocker therapy on survival in severe heart failure
by: William Sanjaya, et al.
Published: (2002-08-01)

Poor tolerance of beta-blockers by elderly patients with heart failure
by: Satoshi Yanagisawa, et al.
Published: (2010-11-01)

Is carvedilol better than other beta-blockers for heart failure?
by: Carmen Rain, et al.
Published: (2015-06-01)

A Review of Randomized Controlled Trials Utilizing Telemedicine for Improving Heart Failure Readmission: Can a Realist Approach Bridge the Translational Divide?
by: Manuel Gonzalez Garcia, et al.
Published: (2019-07-01)

Additive beneficial effects of beta blockers in the prevention of symptomatic heart failure
by: Alberto Genovesi Ebert, et al.
Published: (2016-01-01)

WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT?
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Predictors of Therapeutic Response to Beta-blockers in Patients with Heart Failure in Taiwan
by: Hsin Hu, et al.
Published: (2007-08-01)

Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure.
by: Stephan von Haehling, et al.
Published: (2009-07-01)

Bedside–to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment Criteria
by: P. Iyngkaran, et al.
Published: (2015-08-01)

Bedside–to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients who do Not Meet Trial Enrollment Criteria
by: P. Iyngkaran, et al.
Published: (2015-01-01)

Angiotensin receptor blockers in heart failure
by: Jan Östergren, et al.
Published: (2003-09-01)

Effect of Ivabradine in patients with heart failure in whom beta blockers were contraindicated
by: Aditya Chaudhary, et al.
Published: (2014-11-01)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
by: Kenneth D. Varian, et al.
Published: (2020-10-01)

Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control
by: Wai Bryan, et al.
Published: (2012-02-01)

Angiotensin receptor blockers in heart failure after the ELITE II trial
by: Willenheimer Ronnie
Published: (2000-09-01)

Effects of beta-blockers on heart failure with preserved ejection fraction: a meta-analysis.
by: Feng Liu, et al.
Published: (2014-01-01)

Standing the test of time: exercise testing for heart failure prognosis in the beta-blocker era
by: Marc Simon, et al.
Published: (2013-04-01)

PERCEIVED EXERTION AS AN EXERCISE INTENSITY INDICATOR IN CHRONIC HEART FAILURE PATIENTS ON BETA-BLOCKERS
by: Allan Davie, et al.
Published: (2004-11-01)

EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
by: I. V. Vologdina
Published: (2015-12-01)

Disease-modifying medications in heart failure: more than ACE inhibitors and beta blockers
by: Chia Ter Chao
Published: (2011-01-01)

Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design
by: Kotecha Dipak, et al.
Published: (2013-01-01)

Self-reported and actual beta-blocker prescribing for heart failure patients: physician predictors.
by: Sanjai Sinha, et al.
Published: (2009-12-01)

EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
by: I. V. Vologdina
Published: (2015-12-01)

Rethinking heart failure care and health technologies from early COVID-19 experiences - A narrative review
by: Sakine Satici, et al.
Published: (2021-03-01)

Self-Care Interventions That Reduce Hospital Readmissions in Patients With Heart Failure; Towards the Identification of Change Agents
by: SR Toukhsati, et al.
Published: (2019-06-01)

Interaction of -blockers and angiotensin receptor blockers/ACE inhibitors in heart failure
by: Jay N Cohn
Published: (2003-09-01)

Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta‐blockers in patients hospitalized for acute heart failure
by: Valentina Carubelli, et al.
Published: (2021-06-01)

Patterns of beta-blocker intensification in ambulatory heart failure patients and short-term association with hospitalization
by: Allen Larry A, et al.
Published: (2012-06-01)

Beta Blocker Therapy in Heart Failure Patients with Active Cocaine Use: A Systematic Review
by: Baldeep K. Mann, et al.
Published: (2020-01-01)